Condition
Thyroid Hormones
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Completed4
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06647602Not Yet Recruiting
Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
NCT06793345Not ApplicableCompletedPrimary
Walking Training Improves Thyroid and Cardiometabolic Markers in Postmenopausal Obesity
NCT04124705Phase 2Completed
A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
NCT02997033Completed
SIBlos EXtension Study (SIBEX)
NCT00516555Completed
EBIS: The Eindhoven Breech Intervention Study
NCT00636584Phase 4Unknown
Clinical Study Investigating the Effect of Sodium Nitroprusside Infusion on Thyroidal Function
Showing all 6 trials